Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial-Reference-Cited by-同舟云学术

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial

Published:2023-11-01 Issue:31 Volume:41 Page:4872-4880
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

de Vries Hielke M.¹²^ORCID,Rafael Tynisha S.²^ORCID,Gil-Jimenez Alberto¹³^ORCID,de Feijter Jeantine M.¹,Bekers Elise⁴,van der Laan Elsbeth¹,Lopez-Yurda Marta⁵^ORCID,Hooijberg Erik⁴^ORCID,Broeks Annegien⁶^ORCID,Peters Dennis⁶^ORCID,Seignette Iris M.⁴,Pos Floris J.⁷^ORCID,Horenblas Simon²,van Rhijn Bas W.G.²^ORCID,Jordanova Ekaterina S.²,Brouwer Oscar R.²^ORCID,Schaake Eva⁷,van der Heijden Michiel S.¹³^ORCID

Affiliation:

1. Department of Internal Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

2. Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

3. Department of Molecular Carcinogenesis, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

4. Department of Pathology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

5. Department of Biostatistics, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

6. Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

7. Department of Radiation Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

Abstract

Durable antitumor activity to atezolizumab seen in a subset of patients with advanced penile cancer.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.02894

Reference39 articles.

1. Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015

2. Epidemiological aspects of cancer of the penis in Finland

3. Incidence trends and survival of penile squamous cell carcinoma in the Netherlands

4. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)

5. CISPLATIN, METHOTREXATE AND BLEOMYCIN FOR THE TREATMENT OF CARCINOMA OF THE PENIS: A SOUTHWEST ONCOLOGY GROUP STUDY

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization;European Urology;2024-08

2. Immune-based Therapies for Penile Cancer;Urologic Clinics of North America;2024-08

3. New Therapeutic Horizons for Advanced or Metastatic Penile Cancer;Urologic Clinics of North America;2024-08

4. Management of Bulky Inguinal and Pelvic Lymph Nodes;Urologic Clinics of North America;2024-08

5. Advances in molecular basis of response to immunotherapy for penile cancer: better screening of responders;Frontiers in Oncology;2024-07-17